Eigler A - Search Results

1

Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo.

Brunner C, Seiderer J, Schlamp A, Bidlingmaier M, Eigler A, Haimerl W, Lehr HA, Krieg AM, Hartmann G, Endres S. Brunner C, et al. Among authors: eigler a. J Immunol. 2000 Dec 1;165(11):6278-86. doi: 10.4049/jimmunol.165.11.6278. J Immunol. 2000. PMID: 11086063

2

Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7.

Eigler A, Moeller J, Endres S. Eigler A, et al. J Immunol. 1995 Apr 15;154(8):4048-54. J Immunol. 1995. PMID: 7706743

3

Extracellular ATP and TNF-alpha synergize in the activation and maturation of human dendritic cells.

Schnurr M, Then F, Galambos P, Scholz C, Siegmund B, Endres S, Eigler A. Schnurr M, et al. Among authors: eigler a. J Immunol. 2000 Oct 15;165(8):4704-9. doi: 10.4049/jimmunol.165.8.4704. J Immunol. 2000. PMID: 11035114

4

Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors.

Dauer M, Obermaier B, Herten J, Haerle C, Pohl K, Rothenfusser S, Schnurr M, Endres S, Eigler A. Dauer M, et al. Among authors: eigler a. J Immunol. 2003 Apr 15;170(8):4069-76. doi: 10.4049/jimmunol.170.8.4069. J Immunol. 2003. PMID: 12682236

5

Interferon-alpha disables dendritic cell precursors: dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulation.

Dauer M, Pohl K, Obermaier B, Meskendahl T, Röbe J, Schnurr M, Endres S, Eigler A. Dauer M, et al. Among authors: eigler a. Immunology. 2003 Sep;110(1):38-47. doi: 10.1046/j.1365-2567.2003.01702.x. Immunology. 2003. PMID: 12941139 Free PMC article.

6

ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.

Duewell P, Kisser U, Heckelsmiller K, Hoves S, Stoitzner P, Koernig S, Morelli AB, Clausen BE, Dauer M, Eigler A, Anz D, Bourquin C, Maraskovsky E, Endres S, Schnurr M. Duewell P, et al. Among authors: eigler a. J Immunol. 2011 Jul 1;187(1):55-63. doi: 10.4049/jimmunol.1004114. Epub 2011 May 25. J Immunol. 2011. PMID: 21613613 Free PMC article.

7

Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids.

Sinha B, Semmler J, Eisenhut T, Eigler A, Endres S. Sinha B, et al. Among authors: eigler a. Eur J Immunol. 1995 Jan;25(1):147-53. doi: 10.1002/eji.1830250125. Eur J Immunol. 1995. PMID: 7843225

8

Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells.

Eigler A, Sinha B, Endres S. Eigler A, et al. Biochem Biophys Res Commun. 1993 Oct 15;196(1):494-501. doi: 10.1006/bbrc.1993.2277. Biochem Biophys Res Commun. 1993. PMID: 8216333

9

Specific suppression of human tumor necrosis factor-alpha synthesis by antisense oligodeoxynucleotides.

Hartmann G, Krug A, Eigler A, Moeller J, Murphy J, Albrecht R, Endres S. Hartmann G, et al. Among authors: eigler a. Antisense Nucleic Acid Drug Dev. 1996 Winter;6(4):291-9. doi: 10.1089/oli.1.1996.6.291. Antisense Nucleic Acid Drug Dev. 1996. PMID: 9012865

10

Suppression of tumor necrosis factor-alpha production by interleukin-10 is enhanced by cAMP-elevating agents.

Siegmund B, Eigler A, Moeller J, Greten TF, Hartmann G, Endres S. Siegmund B, et al. Among authors: eigler a. Eur J Pharmacol. 1997 Feb 26;321(2):231-9. doi: 10.1016/s0014-2999(96)00947-8. Eur J Pharmacol. 1997. PMID: 9063693

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters